Galectin Therapeutics Inc. (GALT)
Market Closed
17 Jul, 20:00
$
4. 18
-0.05
-1.182%
$
351.68M Market Cap
- P/E Ratio
- Div Yield
413,700 Volume
-0.66 Eps
$ 4.23
Previous Close Want to track GALT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Galectin Therapeutics Inc. (GALT) Statistics
Valuation metrics
Market Cap 351.68M
Enterprise value 396.56M
Trailing P/E (ttm) -10.26
Forward P/E -
PEG ratio -0.16
Price/Sales (ttm) -
Price/Book (mrq) -2.11
Enterprise Value/Revenue -
Enterprise Value/EBITDA -21.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 920.6K
Average volume (90 days) 704.77K
Price summary
52-Week low 2.03
52-Week high 7.13
Beta -
50-Day moving average 3.99
200-Day moving average 2.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 23 Mar 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.67%
Return on equity 0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.4
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.21
Total debt (mrq) -
Total Debt/Equity (mrq) -1.04
Current ratio (mrq) 2.15%
Book value per share (mrq) -1.98
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
